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http://intl.elsevierhealth.com/journals/ijidEDITORIALCould smallpox come back?The eradication of smallpox, formally concluded by
a World Health Assembly resolution in 1980, may be
considered as one of the most important achieve-
ments in the history of public health. The reasons for
this success are manifold: a highly potent vaccine
was available, which could be produced at low cost,
and in addition to this, many countries provided
financial support for the WHO-led eradication cam-
paign. Perhaps most importantly, numerous highly
motivated individuals devoted their skills and
energy to ridding the planet of one of the most
dreadful infectious diseases known to mankind.
It is indeed sad that after almost 25 years of a
smallpox-free world, there is fear of a deliberate
release of variola virus, the causative agent of small-
pox. It is impossible to estimatehowreal this threat is
and consequently different countries have varying
attitudes towards coping with such an unlikely, but
not impossible event. Some countries simply do not
have the resources to acquire and stockpile smallpox
vaccine, and/or, may have other public health prio-
rities. Other countries may consider the threat as not
being real enough to justify devotingmeans to estab-
lishing counter measures against this unlikely event.
Clearly, the reintroduction of variola virus in the
humanpopulation couldhavecatastrophic conseque-
nces. There is currently very little smallpox immunity
in theworld population since all countries have aban-
donedvaccinationmanyyearsago. Inaddition,dueto
increased mobility of the world population, the dis-
ease may spread very quickly, particularly if the first
caseswerediagnosedata latestage,ormisdiagnosed.
WHO has been instrumental in the eradication of
smallpox and is again expected to play a key role in
coping with the unlikely event of a possible delib-
erate release of variola virus. In fact the organiza-
tion will stockpile smallpox vaccine and make it1201-9712/$30.00 # 2004 International Society for Infectious Diseas
doi:10.1016/j.ijid.2004.09.001available to those countries that have insufficient
supplies, or no supplies at all, in the case that this is
needed. It is therefore essential that WHO receive
the support from the international community to
fulfil its important mission.
On 21—22 October 2003, the ‘‘Smallpox Biosecur-
ity Conference’’ was held in Geneva. The meeting
was sponsored by the smallpox vaccine producing
company Acambis and endorsed by Imperial College
in London and the University of Lausanne. Themeet-
ing provided an opportunity for scientists and public
health experts to discuss issues related to a possible
deliberate release of variola virus. The following
series of 5 papers summarizes some of the subjects
that were discussed in Geneva.
Ken Alibek provides an overview of the disease
smallpox and attempts made by the former Soviet
Union to develop the variola virus as a biological
weapon. Georges Gouvras describes countermea-
sures put in place by the European Union to deal with
a smallpox outbreak. DavidHeymann summarizes the
WHO smallpox eradication program and the lessons
that were learnt from it. Tom Monath describes the
development of a second-generation smallpox vac-
cine. Finally, Jean Pascal Zanders assesses the threat
of a deliberate release of variola virus and discusses
measures to minimize the consequences.
Together the following papers not only give an
accurate account of the current issues surrounding
smallpox, but should also make us confident that a
smallpox outbreak could be dealt with, should this
ever occur, which we all hope will not be the case.R. Wittek
Inst. de Biotechnologie, Baˆtiment de Biologie
1015 Lausanne, Switzerland
Tel.: +41 21 692 41 12; fax: +41 21 692 41 15
E-mail address: riccardo.wittek@ibt.unil.ches. Published by Elsevier Ltd. All rights reserved.
